Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Patients & Carers meeting December 2013
January 10, 2019
Patients & Carers meeting November 2013
January 10, 2019
Patients & Carers meeting October 2013
January 10, 2019
Patients and Carers meeting September 2013
January 10, 2019
Patients and Carers meeting August 2013
January 10, 2019
Patients and Carers meeting July 2013
January 10, 2019
Patients and Carers meeting June 2013
January 10, 2019
Patients and Carers meeting May 2013
January 10, 2019
Film: Faces From The ICU
December 13, 2018
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video